Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Seminars in Reproductive Medicine
|
February 17, 2005
Mifepristone in abortion care
Courtney Schreiber, Mitchell Creinin
Journal of Women'S Health (2002)
|
December 17, 2008
The impact of race and ethnicity on receipt of family planning services in the United States
Sonya Borrero, Eleanor B Schwarz, Mitchell Creinin, et al.
Contraception
|
February 19, 2026
Exploring how California obstetrician-gynecologists interpret the fetal viability concept
Natalie DiCenzo, Katie Donnelly, Melissa Gosdin, et al.
JMIR Research Protocols
|
May 10, 2021
Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study
Alison Edelman, Agnes Hemon, Mitchell Creinin, et al.
Contraception
|
October 18, 2022
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials
Melissa J Chen, Jeffrey T Jensen, Andrew M Kaunitz, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Seminars in Reproductive Medicine
|
February 17, 2005
Mifepristone in abortion care
Courtney Schreiber, Mitchell Creinin
Journal of Women'S Health (2002)
|
December 17, 2008
The impact of race and ethnicity on receipt of family planning services in the United States
Sonya Borrero, Eleanor B Schwarz, Mitchell Creinin, et al.
Contraception
|
February 19, 2026
Exploring how California obstetrician-gynecologists interpret the fetal viability concept
Natalie DiCenzo, Katie Donnelly, Melissa Gosdin, et al.
JMIR Research Protocols
|
May 10, 2021
Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study
Alison Edelman, Agnes Hemon, Mitchell Creinin, et al.
Contraception
|
October 18, 2022
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials
Melissa J Chen, Jeffrey T Jensen, Andrew M Kaunitz, et al.
Page
of 1